COVID-19 Vaccine Effectiveness and Risk Factors in Andalusia, Spain
Author Information
Author(s): Serrano-Ortiz Álvaro, Romero-Cabrera Juan Luis, Monserrat Villatoro Jaime, Cordero-Ramos Jaime, Ruiz-Montero Rafael, Ritoré Álvaro, Dopazo Joaquín, del Diego Salas Jorge, García Sánchez Valle, Salcedo-Leal Inmaculada, Armengol de la Hoz Miguel Ángel, Túnez Isaac, Guzmán Miguel Ángel
Primary Institution: Reina Sofía University Hospital, Córdoba, Spain
Hypothesis
What are the risk factors and vaccine effectiveness on COVID-19-related hospital admissions, ICU admissions, and mortality in the Andalusian population?
Conclusion
The study found that COVID-19 vaccination reduces hospital admissions, ICU admissions, and mortality, but effectiveness wanes over time, especially in older individuals.
Supporting Evidence
- COVID-19 vaccination reduced hospital admissions, ICU admissions, and deaths.
- Older age and chronic diseases were significant risk factors for severe outcomes.
- Vaccine effectiveness decreased over time, particularly after six months.
- Three doses of the vaccine provided the most protection against severe outcomes.
- Male sex was associated with higher odds of hospital admission and mortality.
- Individuals aged 60 and older showed increased risk of severe outcomes after vaccination.
Takeaway
Getting vaccinated helps protect against serious illness from COVID-19, but the protection can wear off over time, especially for older people.
Methodology
A retrospective cohort study using electronic health records from the Andalusian public health system, analyzing data from March 2020 to April 2022.
Potential Biases
Potential biases due to underrepresentation of mild cases and missing data on certain risk factors.
Limitations
The study may not represent mild COVID-19 cases diagnosed with rapid tests, and some risk factors like obesity and smoking were not recorded.
Participant Demographics
The study included individuals from the Andalusian public health system, with a focus on those aged 60 and older and those with chronic diseases.
Statistical Information
P-Value
p<0.01
Confidence Interval
95% CI 1.10–1.32
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website